High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$84.7M
$84,662,132
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
JNJ
S
JOHNSON & JOHNSON
Decker Robert J
• Officer • VP Corporate Controller
Discretionary SellΔOwn -14.7%
2026-02-27
$1,010,070Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • VP Corporate Controller
Discretionary SellΔOwn -14.7%
|
2026-02-27 | $1,010,070Large | S | Form 4 |
| JNJ |
JOHNSON & JOHNSON
|
Chair
Discretionary Sell
|
2026-02-20 | $324,763 | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Schmid Timothy
• Chair
Discretionary SellΔOwn -25.2%
2026-02-18
$5,527,506Whalex2
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Chair
Discretionary SellΔOwn -25.2%
|
2026-02-18 | $5,527,506Whalex2 | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Broadhurst Vanessa
• Officer • EVP, Global Corp Affairs
Discretionary SellΔOwn -21.2%
2026-02-17
$1,508,288Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Global Corp Affairs
Discretionary SellΔOwn -21.2%
|
2026-02-17 | $1,508,288Large | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -17.6%
2026-02-17
$13,105,233MEGAx3
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -17.6%
|
2026-02-17 | $13,105,233MEGAx3 | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Swanson James D.
• Officer • EVP, CIO
Discretionary SellΔOwn -44.4%
2026-02-17
$4,980,447Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, CIO
Discretionary SellΔOwn -44.4%
|
2026-02-17 | $4,980,447Large | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Wolk Joseph J
• CFO
Discretionary SellΔOwn -23.6%
2026-02-17
$21,767,827MEGAx4
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
CFO
Discretionary SellΔOwn -23.6%
|
2026-02-17 | $21,767,827MEGAx4 | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Swanson James D.
• Officer • EVP, CIO
Discretionary SellΔOwn -43.6%
2026-02-13
$10,129,312MEGAx2
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, CIO
Discretionary SellΔOwn -43.6%
|
2026-02-13 | $10,129,312MEGAx2 | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
Duato Joaquin
• CEO
Discretionary SellΔOwn -39.1%
2026-01-26
$22,122,893MEGAx2
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
CEO
Discretionary SellΔOwn -39.1%
|
2026-01-26 | $22,122,893MEGAx2 | S | Form 4 |
|
JNJ
S
JOHNSON & JOHNSON
REED JOHN C
• Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -67.1%
2025-10-17
$4,185,793Large
|
||||||
| JNJ |
JOHNSON & JOHNSON
|
Officer • EVP, Innovative Medicine, R&D
Discretionary SellΔOwn -67.1%
|
2025-10-17 | $4,185,793Large | S | Form 4 |